Company: INMB
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001213900-25-073077
Chunk: 214

Company: Inmune Bio, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part II, Item 5
Chunk 214
---
    101.INS
     
    Inline XBRL Instance Document.

    101.SCH
     
    Inline XBRL Taxonomy Extension Schema Document.

    101.CAL
     
    Inline XBRL Taxonomy Extension Calculation Linkbase Document.

    101.DEF
     
    Inline XBRL Taxonomy Extension Definition Linkbase Document.

    101.LAB
     
    Inline XBRL Taxonomy Extension Label Linkbase Document.

    101.PRE
     
    Inline XBRL Taxonomy Extension Presentation Linkbase Document.

    104
     
    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*Filed herewith.

**Furnished herewith.

†Certain confidential information contained in this agreement
has been omitted because it is both not material and is the type that the registrant treats as private or confidential.

39

SIGNATURES

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.

    INmune Bio Inc. 

    Date: August 7, 2025
    By:
    /s/ David Moss

    David Moss

    Principal Executive Officer

    (Principal Executive Officer)

    Date: August 7, 2025 
    By:
    /s/ Cory Ellspermann

    Cory Ellspermann

    Interim Chief Financial Officer

    (Principal Financial and Accounting Officer)

40

0001711754
false
Q2
--12-31

    0001711754

    2025-01-01
    2025-06-30

    0001711754

    2025-08-07

    0001711754

    2025-06-30

    0001711754

    2024-12-31

    0001711754
    
      us-gaap:RelatedPartyMember

    2025-06-30

    0001711754
    
      us-gaap:RelatedPartyMember

    2024-12-31

    0001711754

    2025-04-01
    2025-06-30

    0001711754

    2024-04-01
    2024-06-30